Your Health, We Care
Release date: 2026-01-05 14:57:14 Recommended: 37
Applicable for the treatment of adult patients with advanced or metastatic breast cancer who are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative.
